Buys
Open market- Shares
- Avg price
- Total value
John Aballi - President and CEO, Director at EXAGEN INC.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- XGN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for John Aballi in EXAGEN INC.
Sells
Open market- Shares
- -58,915
- Avg price
- $8.04
- Total value
- -$473,687
Net
Past year- Shares
- -58,915
- Share %
- -100%
- Total value
- -$473,687
Reported holdings for John Aballi in EXAGEN INC.
Form 4 holding
President and CEO, Director
EXAGEN INC.
- Security class
- Common Stock
- Shares / value
- 839,834
- Estimated value
- $2,721,062
- Report date
- 12 Mar 2026
- Price
- $3.24
- Ownership
- Direct
Form 4 holding
President and CEO, Director
EXAGEN INC.
- Security class
- Common Stock
- Shares / value
- 40,401
- Estimated value
- $130,899
- Report date
- 12 Mar 2026
- Price
- $3.24
- Ownership
- by Spouse
Form 4 holding
President and CEO, Director
EXAGEN INC.
- Security class
- Stock Option(right to buy)
- Shares / value
- 175,000
- Estimated value
- Report date
- 12 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John Aballi in EXAGEN INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.